PharmacologyNCIt concept

https://www.has-sante.fr/jcms/p_3503157/fr/firehawk
2024
France
health technology assessment
Coronary Artery Stent
Stenting
Pharmacology
Product Part
Coat
pharmacology
Stent
Endoprosthesis
stents
Joy
Pet is as Active as it Has Been
pharmacologist
Sirolimus
sirolimus
Cover
Active State
Active License
Active Control

---
https://www.has-sante.fr/jcms/p_3512096/fr/resolute-integrity
2024
France
health technology assessment
Pet is as Active as it Has Been
Active State
Coronary Artery Stent
Pharmacology
Zotarolimus
Active Control
Joy
pharmacologist
pharmacology
Coat
Endoprosthesis
Stenting
zotarolimus
Cover
Active License
stents
Stent
zotarolimus
Product Part

---
https://www.cfp.ca/content/69/10/e202
2023
Canada
journal article
Care
duration
patient care management
sexual behavior, nos
Long-Term care
pharmacology
Residence
Pharmacology
Sex Behavior
sexual behavior
How True Feel Carefree Right Now
pharmacologist
Charge
dental behavior management, nos
inappropriate behavior
Healthcare
Inappropriate
Long-Term
Healthcare Activity

---
https://www.has-sante.fr/jcms/p_3482927/fr/avantgarde-chrono-carbostent
2023
France
health technology assessment
pharmacologist
Carbon
carbon, nos
Stent
pharmacologic actions
Pharmacology
Endoprosthesis
Cover
Regulatory Action
stents
Coronary Artery Stent
Product Part
Stenting
Pharmacologic Substance
Joy
carbon
Coat

---
https://www.minerva-ebp.be/Theme/Analysis/845
2023
Belgium
critical appraisal or critical reading
No History of Non-Cardiac Surgery
Documentation Absent
No History of Myopathy
Therapeutic Ionizing Radiation to Head History Absent
PTEN Gene Mutation Negative
ROS1 Rearrangement Analysis Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
Chemotherapy Not Received
Chief Complaint Not Caused by Trauma
IDH Family Wildtype
EGFR Amplification Analysis Was Not Performed
Preoperative IV Antiemetics were not Administered
Intervention Not Given for Kawasaki Disease
Paraneoplastic Syndrome is Not Present
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
PTEN Mutation Analysis Was Not Performed
Any Metastatic Diagnosis Absent
Another Form of Birth Control was not Used
Pharmacology
No Known History of Illicit Drug Use
Additional Surgery for New Tumor Event Absent
ATRX Mutation Analysis Was Not Performed
Chief Complaint was Not Witnessed
No History of Neonatal Complication
BRAF Mutation Analysis Was Not Performed
Preoperative IV Antacids were not Administered
MGMT Promoter Methylation Testing Was Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
No History of Gestational Complication
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Immunohistochemistry Was Not Performed
Lymph Node Dissection Was Not Performed
Radiation Therapy Not Received
ALK Rearrangement Analysis Was Not Performed
Cancer History Absent
Radiation History Negative
NON Mouse
EGFR Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
Medication Not Taken
ATRX Gene Mutation Negative
ERBB2 Mutation Analysis Was Not Performed
History of Medical Treatment Absent
Physician Diagnosed Diabetes Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Caffeine Not Routinely Consumed
Intercurrent Illness is Absent at Onset of Chief Complaint
Local Anesthesia Agents were not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
History of Colorectal Cancer Negative
IV Anesthesia was not Administered
No Known History of Alcohol Use
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
BRAF Rearrangement Analysis Was Not Performed
Preoperative IV Sedation was Not Administered
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
KRAS Mutation Analysis Was Not Performed
Has No Sibling
MET Mutation Analysis Was Not Performed
First Degree Family History Cancer Negative
Neither
EGFR Gene Amplification Negative
IDH Family Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
Tumor Progression Absent After Initial Treatment
Family History of Stomach Cancer Absent
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
No Response to Intervention for Kawasaki Disease
What Month is it
First Degree Family History Thyroid Cancer Negative
NF1 Mutation Analysis Was Not Performed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Patient was not Postmenopausal with no Prior Oophorectomy
RET Rearrangement Analysis Was Not Performed
frail elderly
Patient was Not Previously Evaluated for Current Chief Complaint
Neither Case or Control Status
1p/19q Deletion Analysis Was Not Performed
Routine Cytogenetics Were not Completed
pharmacologist
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Unemployed
Not Lost to Follow-Up
Regional Anesthesia was not Administered
Adjuvant I-131 Therapy Negative
Use of Smokeless Tobacco at Time of Diagnosis Negative
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Nitric Oxide
elderly person, nos
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
pharmacology
New Tumor Event After Initial Treatment Absent
KIT Mutation Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Other Preoperative IV Medications were not Administered
PDGFRA Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Additional Molecular Studies Were Not Performed
SDH Complex Mutation Analysis Was Not Performed
Preoperative IV Opiates were not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Chemotherapy Was Not Administered
Elderly
Nitric Oxide Measurement
Negation
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Norway
No History of Congenital Heart Disease
Chemical/Occupational Exposure Absent
No History of Rheumatic Fever
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
10q23/PTEN Locus Deletion Analysis Was Not Performed
New Disease is not Multifocal
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Kawasaki Disease
Evidence of Disease Absent after Completion of Therapy
NRAS Mutation Analysis Was Not Performed
Hypertension Absent

---
https://www.has-sante.fr/jcms/p_3465342/fr/supraflex-cruz-nevo
2023
France
health technology assessment
sirolimus
stents
Cover
Pharmacology
Sirolimus
Active License
Product Part
Active Control
Coat
Joy
Stent
Pet is as Active as it Has Been
Stenting
nevo syndrome
pharmacologist
Coronary Artery Stent
Endoprosthesis
pharmacology
Active State

---
https://www.has-sante.fr/jcms/p_3463641/fr/biomatrix-flex
2023
France
health technology assessment
Pharmacology
Stent
Active License
Pharmacologic Substance
Joy
pharmacologist
Active Control
Active State
stents
Pet is as Active as it Has Been
Endoprosthesis
Coronary Artery Stent
Stenting
Coat
pharmacology
Product Part
Cover

---
https://www.has-sante.fr/jcms/p_3474526/fr/pro-kinetic-energy
2023
France
health technology assessment
pharmacologist
stents
Silicon
silicon carbide
Product Part
silicon carbide
silicon carbide
Stenting
Endoprosthesis
Stent
Proline Measurement
Pharmacology
Cover
Patient Reported Outcome
Proline
Coat
Pharmacologic Substance
Coronary Artery Stent
silicon
pharmacologic actions
Joy
Regulatory Action
proline
PRO Mouse

---